TAG
Neuroprotective at 5-20mg daily; regulatory ambiguity between pharmaceutical lithium and supplements
13 Apr 2026
Low Dose Naltrexone (LDN)
13 Apr 2026
5-alpha reductase inhibitor: approved for BPH, off-label for androgenetic alopecia
13 Apr 2026
Cabergoline
13 Apr 2026
Alpha-glucosidase inhibitor: approved for type 2 diabetes, longevity potential in animal models
13 Apr 2026
Bug report, content request, or general comment — we read everything.